The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.

The statin family of cholesterol-lowering drugs is known to have pleiotropic properties which include anti-inflammatory and immunomodulatory effects. Statins exert their pleiotropic effects by altering expression of human immune regulators including pro-inflammatory cytokines. Previously we found th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emma Hennessy, Julie O'Callaghan, Marlies J Mooij, Claire Legendre, Olga Camacho-Vanegas, Sandra C Camacho, Claire Adams, John A Martignetti, Fergal O'Gara
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/21193d5fc4c94b3cbef819c9f1935b9f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:21193d5fc4c94b3cbef819c9f1935b9f
record_format dspace
spelling oai:doaj.org-article:21193d5fc4c94b3cbef819c9f1935b9f2021-11-25T06:09:02ZThe impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.1932-620310.1371/journal.pone.0102200https://doaj.org/article/21193d5fc4c94b3cbef819c9f1935b9f2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25010049/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203The statin family of cholesterol-lowering drugs is known to have pleiotropic properties which include anti-inflammatory and immunomodulatory effects. Statins exert their pleiotropic effects by altering expression of human immune regulators including pro-inflammatory cytokines. Previously we found that statins modulate virulence phenotypes of the human pathogen Pseudomonas aeruginosa, and sought to investigate if simvastatin could alter the host response to this organism in lung epithelial cells. Simvastatin increased the expression of the P. aeruginosa target genes KLF2, KLF6, IL-8 and CCL20. Furthermore, both simvastatin and P. aeruginosa induced alternative splicing of KLF6. The novel effect of simvastatin on wtKLF6 expression was found to be responsible for induction of the KLF6 regulated genes CCL20 and iNOS. Simvastatin also increased the adhesion of P. aeruginosa to host cells, without altering invasion or cytotoxicity. This study demonstrated that simvastatin had several novel effects on the pulmonary cellular immune response.Emma HennessyJulie O'CallaghanMarlies J MooijClaire LegendreOlga Camacho-VanegasSandra C CamachoClaire AdamsJohn A MartignettiFergal O'GaraPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 7, p e102200 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Emma Hennessy
Julie O'Callaghan
Marlies J Mooij
Claire Legendre
Olga Camacho-Vanegas
Sandra C Camacho
Claire Adams
John A Martignetti
Fergal O'Gara
The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.
description The statin family of cholesterol-lowering drugs is known to have pleiotropic properties which include anti-inflammatory and immunomodulatory effects. Statins exert their pleiotropic effects by altering expression of human immune regulators including pro-inflammatory cytokines. Previously we found that statins modulate virulence phenotypes of the human pathogen Pseudomonas aeruginosa, and sought to investigate if simvastatin could alter the host response to this organism in lung epithelial cells. Simvastatin increased the expression of the P. aeruginosa target genes KLF2, KLF6, IL-8 and CCL20. Furthermore, both simvastatin and P. aeruginosa induced alternative splicing of KLF6. The novel effect of simvastatin on wtKLF6 expression was found to be responsible for induction of the KLF6 regulated genes CCL20 and iNOS. Simvastatin also increased the adhesion of P. aeruginosa to host cells, without altering invasion or cytotoxicity. This study demonstrated that simvastatin had several novel effects on the pulmonary cellular immune response.
format article
author Emma Hennessy
Julie O'Callaghan
Marlies J Mooij
Claire Legendre
Olga Camacho-Vanegas
Sandra C Camacho
Claire Adams
John A Martignetti
Fergal O'Gara
author_facet Emma Hennessy
Julie O'Callaghan
Marlies J Mooij
Claire Legendre
Olga Camacho-Vanegas
Sandra C Camacho
Claire Adams
John A Martignetti
Fergal O'Gara
author_sort Emma Hennessy
title The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.
title_short The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.
title_full The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.
title_fullStr The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.
title_full_unstemmed The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.
title_sort impact of simvastatin on pulmonary effectors of pseudomonas aeruginosa infection.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/21193d5fc4c94b3cbef819c9f1935b9f
work_keys_str_mv AT emmahennessy theimpactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT julieocallaghan theimpactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT marliesjmooij theimpactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT clairelegendre theimpactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT olgacamachovanegas theimpactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT sandraccamacho theimpactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT claireadams theimpactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT johnamartignetti theimpactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT fergalogara theimpactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT emmahennessy impactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT julieocallaghan impactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT marliesjmooij impactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT clairelegendre impactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT olgacamachovanegas impactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT sandraccamacho impactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT claireadams impactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT johnamartignetti impactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
AT fergalogara impactofsimvastatinonpulmonaryeffectorsofpseudomonasaeruginosainfection
_version_ 1718414091630936064